FindTrial
Sign In

An international observational study to describe the modality of fluid administration in Intensive Care Unit

Fluid challenge in Intensive Care: a worldwide global inception cohort study. The FENICE II study. - FENICE II study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/079900
Enrollment
10000
Registered
2025-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: C00-D49- Neoplasms

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

IRCCS Humanitas Research Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive adult patients admitted to ICU and expected to stay at least 48h

Exclusion criteria

Exclusion criteria: Planned admission after surgery for overnight ICU stay Refusal of consent Moribund patients (i.e. expected survival less than 24h)

Design outcomes

Primary

MeasureTime frame
To describe the modality of fluid administration during the first 5 days of ICU stay considering 1) the overall fluid balance; 2) the characteristics of the fluids given; 3) the modality of fluid administration (i.e. FC and not FC).Timepoint: At 5 days of ICU admission—

Secondary

MeasureTime frame
1. To explore any association between fluid administration characteristics & clinical outcomes 2. To evaluate factors potentially associated with the respective proportion of the different modalities of fluid administration 3. To characterize FC administration modality in a large cohort of ICU patientsTimepoint: At 30 days of ICU admission—

Countries

Belgium, France, Ireland, Italy, Netherlands, Sweden, United Kingdom

Contacts

Public ContactDr Sheila N Myatra

Tata Memorial Hospital

sheila150@hotmail.com9820156070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026